U.S. Insurance Stock News

Schneider National (NYSE:SNDR) announced a planned leadership transition, with Jim Filter set to become CEO. Current CEO Mark Rourke will move into the role of Executive Chairman as part of the succession plan. The transition highlights Schneider National’s focus on continuity while bringing Filter’s operational and commercial background to the top role. Schneider National is a major player in truckload, intermodal, and logistics services, so a leadership change at the top matters for...

If you are wondering whether American International Group's current share price still lines up with its underlying worth, you are not alone. This article is built to help you frame that question clearly. The stock last closed at US$75.96, with recent returns of 2.2% over 7 days, a 2.7% decline over 30 days, a 9.9% decline year to date and gains of 4.0% over 1 year, 33.4% over 3 years and 104.6% over 5 years. This pattern hints that the market has shifted its view several times over different...

If you are wondering whether Phillips 66 is still attractively priced after its recent run, this breakdown will help you see what the current share price might be implying. The stock last closed at US$154.43, with returns of 7.2% over the past week, 13.0% over the past month, 18.3% year to date and 32.6% over the past year, alongside 68.6% over three years and 143.1% over five years. Recent coverage around Phillips 66 has focused on how investors are reassessing refiners and energy...

Q1 2026 headline results and recent momentum Construction Partners (ROAD) opened its Q1 2026 update with total revenue of US$809.5 million and basic EPS of US$0.31, anchored by net income of US$17.2 million for the quarter. Over recent periods, the company has seen revenue move from US$561.6 million and a basic EPS loss of US$0.06 in Q1 2025 to US$899.8 million with EPS of US$1.02 in Q4 2025. Trailing 12 month EPS reached US$2.20 on net income of US$122.0 million. This sets the stage for...

Intuit (INTU) is back in focus after a steep selloff in software stocks, as fresh AI disruption worries, OpenAI’s new enterprise platform, and analyst downgrades collide with new product partnerships such as Affirm integration. See our latest analysis for Intuit. Those AI worries and analyst downgrades have shown up clearly in the chart, with Intuit’s share price down 32.8% on a 1 month basis and 30.9% year to date, while the 5 year total shareholder return of 9.8% is far less dramatic...

Why Netskope Stock Is Drawing Investor Attention Netskope (NTSK) is back on investors’ radar after recent trading moves, with the share price sitting at US$11.53 and short term returns under pressure over the past week and month. See our latest analysis for Netskope. The 1 day share price return of a 12.09% decline and a 7 day share price return of a 24.92% decline sit within a tougher stretch, with the 90 day share price return down 48.36%. This signals fading momentum despite Netskope’s...

Thermo Fisher Scientific (NYSE:TMO) is closing its Franklin, Massachusetts facility and winding down operations, with significant job reductions as part of a broader restructuring. The company has agreed to acquire clinical trial and digital data specialist Clario for about $9 billion in cash. These moves reshape Thermo Fisher’s operational footprint and expand its reach in clinical research and digital health solutions. For investors watching NYSE:TMO, these announcements come at a time of...

Northrop Grumman (NOC) is back in focus after reporting full year 2025 earnings, with revenue of US$41.954b and net income of US$4.182b, along with new defense contract wins in microelectronics and threat training systems. See our latest analysis for Northrop Grumman. The earnings release and fresh contracts in microelectronics and threat training systems come after a strong run in the shares, with a 30 day share price return of 14.1% and a 1 year total shareholder return of 51.9%, which...

Why GigaCloud Technology (GCT) is on investors’ radar today GigaCloud Technology (GCT) has drawn attention after recent trading, with the stock last closing at $38.57 and showing mixed short term performance, including a 1 day decline and a weaker past month. For context, the shares show a negative past week return and a negative month move, set against a positive past 3 months and a strong 1 year total return. That blend of shorter term softness and longer term strength is where many...

Recent coverage around Niagen Bioscience (NAGE) has focused on upcoming launches with major consumer product partners and fresh clinical data tied to its FDA recognized nicotinamide riboside, which has pushed the stock back onto investors’ watchlists. See our latest analysis for Niagen Bioscience. Despite the recent excitement around new partner launches and clinical readouts, Niagen Bioscience’s share price has pulled back. The 30 day share price return shows a 24.11% decline and the 90 day...

Multiple securities class action lawsuits have been filed against BellRing Brands (NYSE:BRBR), alleging the company misled investors about the drivers of its sales growth. Plaintiffs claim BellRing tied strong sales to sustainable demand rather than customer inventory stockpiling and did not fully disclose weakening demand and rising competition. The lawsuits, which also name certain executives, raise questions about BellRing's disclosures and could affect investor confidence and corporate...

If you are wondering whether MGM Resorts International is priced fairly or offering value right now, you will want to look closely at how its current share price lines up with different valuation checks. The stock recently closed at US$36.28, with returns of 8.8% over the past 7 days, 1.5% over 30 days, a slight return of negative 0.6% year to date, 5.2% over 1 year, negative 17.7% over 3 years, and 2.8% over 5 years. This set of figures gives a mixed picture of recent and longer term...

Recent gains in Quanta Services (PWR) have drawn attention as investors weigh the company’s revenue and earnings growth, sizeable contract backlog, and upcoming February 19 earnings report against rising interest in data center power infrastructure. See our latest analysis for Quanta Services. The recent 1 month share price return of 9.01% and 1 day move of 2.83%, taking Quanta Services to US$477.72, sit alongside a 1 year total shareholder return of 53.74% and a very large 5 year total...

Mondelez International (NasdaqGS:MDLZ) has appointed longtime CFO Luca Zaramella as Chief Operating Officer. Zaramella will oversee commercial operations, sales, marketing, and supply chain while the company searches for a new CFO. He will temporarily hold both the COO and CFO positions, concentrating executive authority over Mondelez's global operations. For investors watching Mondelez International at a share price of $60.31, this leadership change follows mixed medium term returns. The...

Why WEC Energy Group Is Back in Focus WEC Energy Group (WEC) landed on investor radars after fourth quarter results topped earnings and revenue forecasts, paired with reaffirmed 2026 guidance and a proposed settlement that clears key Illinois regulatory issues. See our latest analysis for WEC Energy Group. After the earnings beat, reaffirmed 2026 guidance and the proposed Illinois settlement, the current US$111.94 share price sits against a 30 day share price return of 5.65% and a 1 year...

Toll Brothers (TOL) has been busy, rolling out and planning new luxury communities across Florida, California, Nevada, Georgia, Pennsylvania, Michigan, New York, Texas, and more. This burst of development helps frame how investors might think about the stock today. See our latest analysis for Toll Brothers. The recent string of community launches across Florida, California, Nevada, Georgia, Pennsylvania, Michigan, New York, Texas, and New Jersey has come alongside a 30 day share price return...

Viatris Inc. recently announced that veteran pharmaceutical lawyer Matthew J. Maletta will become Chief Legal Officer on February 9, 2026, succeeding long-serving CLO Brian Roman, who will stay on as an advisor until April 1, 2026 to support the handover. Maletta’s background in managing complex transactions and legal teams across both generic and branded drug companies introduces a new legal leadership profile for Viatris as it continues its operational transformation. We’ll now examine how...

U.S. executive actions are being discussed that could support TMC the metals through the Defense Production Act and related measures. These actions may include direct U.S. government equity investment in NasdaqGS:TMC to back its deep sea mining projects for critical battery metals. The potential support is tied to efforts to broaden supply chains for electric vehicle and renewable energy materials away from heavy reliance on China. NasdaqGS:TMC sits in a unique spot as it focuses on large...

UnitedHealth Group (NYSE:UNH) is facing a proposed Department of Labor rule aimed at increasing transparency around Pharmacy Benefit Manager compensation. The company is also under Department of Justice investigation regarding its Medicare billing practices. These developments introduce regulatory, legal, and reputational risks that could affect parts of UnitedHealth's business model. UnitedHealth Group operates a broad health care business that includes insurance benefits and pharmacy...

Why CNO’s latest earnings matter for shareholders CNO Financial Group (CNO) reported fourth quarter and full year 2025 results with revenue slightly higher than a year earlier, while net income and earnings per share came in lower than the prior year. The update gave investors a fresh look at how this insurance provider is balancing growth in its top line with pressure on profitability, and it has become a focal point for how the stock is being reassessed after earnings. See our latest...

Houlihan Lokey (HLI) is back in focus after quarterly results topped Wall Street forecasts, supported by active Corporate Finance work, heavier private equity deal flow, and fresh commentary around data monetization and European expansion. See our latest analysis for Houlihan Lokey. Recent news around earnings, European hiring and the completed share repurchase comes against a weaker price backdrop, with a 30 day share price return of 9.24% and a 1 year total shareholder return of 9.2%. The 3...

Zevra Therapeutics (ZVRA) is back on investors’ radar after presenting new real world and clinical data on its approved Niemann Pick disease type C therapy MIPLYFFA at the 22nd Annual WORLDSymposium, alongside progress in Europe. See our latest analysis for Zevra Therapeutics. Zevra’s share price has been choppy recently, with a 1 day share price return of 6.49% and a 7 day share price return of 5.64% around the WORLDSymposium data. Its 1 year total shareholder return of 6.09% sits against a...

PagSeguro Digital (PAGS) is back on investors’ radar after recent share price volatility, with the stock closing at US$10.61 following mixed short term performance and stronger returns over the past year. See our latest analysis for PagSeguro Digital. That recent 1-day share price return of -2.30% and 7-day share price return of -11.58% comes after a steadier backdrop, with a 90-day share price return of 14.58% and 1-year total shareholder return of 45.88%. This suggests momentum has cooled...

If you are wondering whether TopBuild's current share price still offers value, this article will walk through what the numbers are saying about the stock. The shares last closed at US$493.91, with returns of 2.9% over 7 days, 11.0% over 30 days, 14.5% year to date, 45.6% over 1 year and 151.1% over 3 years. These figures set the scene for a closer look at what investors are currently paying. Recent attention on TopBuild has been shaped by ongoing interest in the building products and...